X-Chem, Inc. Tech Stack

DNA-encoded chemistry + AI platform for small-molecule drug discovery

Biotechnology Research Waltham, MA 201–500 employees Founded 2010 Privately Held

X-Chem pairs DNA-encoded chemical libraries with machine learning to accelerate early-stage drug discovery for pharma and biotech partners. The tech stack reveals a hybrid architecture: Docker + Kubernetes on AWS for cloud-native services, alongside chemistry-specific tools (RDKit) and legacy databases (Oracle, PostgreSQL, MongoDB), with ML property prediction now in active development. Current hiring skews heavily research (3 of 6 roles) while tackling backend modernization and cross-product integration—suggesting the company is scaling discovery throughput while addressing infrastructure debt.

Tech Stack 24 technologies

Core StackAWS Docker Kubernetes AWS Lambda PostgreSQL MongoDB Oracle Java Python C# React VMware Hyper-V NetSuite Salesforce Power BI Tableau AWS EKS JSF RDKit Ubuntu Red Hat SuccessFactors

What X-Chem, Inc. Is Building

◆Challenges

Integrating legacy products into cloud-native platform
Modernizing legacy components
Improving interoperability and data flow
Inefficient it purchasing procedures
Inventory management inefficiencies
License management complexity
Streamlining onboarding/offboarding
Reporting for leadership

▲Active Projects

Cloud-native backend services development
Integration of three in-house products
Modernization of legacy components
Onboarding/offboarding activities
Kpi and sla reporting
Process improvement and documentation
Ml property prediction for drug discovery
Chemical data workflow development
Data integration across drug discovery
Hr process improvement initiative

Hiring Activity

Accelerating6 roles · 4 in 30d

Department

Research

Engineering

Support

Seniority

Mid

Intern

Junior

Senior

Company intelligence

Find more companies like X-Chem, Inc. by tech stack, pain points and active projects

Get started free

About X-Chem, Inc.

X-Chem, founded in 2010 and headquartered in Waltham, MA, develops a platform combining DNA-encoded chemical library technology, discovery chemistry, and AI to help pharmaceutical and biotech companies identify drug candidates. The company reports an 80% success rate in hit identification, ~100 programs licensed by partners, and 4 clinical candidates advanced since 2021. X-Chem serves partners across multiple discovery stages—screen-to-hit, hit-to-lead, lead optimization, and candidate identification—and offers flexible engagement models: full project support, screening services, or standalone access to their ArtemisAI software. The organization operates at 201–500 employees and actively hires across research, engineering, HR, and support functions in the United States, Hungary, and Canada.

HeadquartersWaltham, MA

Company Size201–500 employees

Founded2010

Hiring MarketsUnited States, Hungary, Canada

Frequently Asked Questions

What is X-Chem's technology platform?

X-Chem combines DNA-encoded chemical library screening, discovery chemistry expertise, and machine learning (ArtemisAI software) to identify small-molecule drug candidates. The platform supports partners from initial screening through lead optimization and candidate selection.

What tech stack does X-Chem use?

AWS (EKS, Lambda), Docker, Kubernetes, PostgreSQL, MongoDB, Oracle, Java, Python, React, RDKit (chemistry toolkit), Salesforce, and Power BI. The stack reflects both cloud-native backend services and chemistry-specific tooling for drug discovery workflows.

How this profile is built

X-Chem, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.